147 related articles for article (PubMed ID: 36900332)
1. Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990-2019).
Boer FL; Ho VKY; Louwman MWJ; Schrader AMR; Zuur CL; Blank CU; van Poelgeest MIE; Kapiteijn EHW
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900332
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based study.
van Zeijl MCT; Boer FL; van Poelgeest MIE; van den Eertwegh AJM; Wouters MWJM; de Wreede LC; Aarts MJB; van den Berkmortel FWPJ; de Groot JWB; Hospers GAP; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; Boers-Sonderen MJ; Kapiteijn EHW; Haanen JBAG
Eur J Cancer; 2020 Sep; 137():127-135. PubMed ID: 32763783
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
4. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands.
Pleunis N; Schuurman MS; Van Rossum MM; Bulten J; Massuger LF; De Hullu JA; Van der Aa MA
Gynecol Oncol; 2016 Sep; 142(3):440-5. PubMed ID: 27126004
[TBL] [Abstract][Full Text] [Related]
5. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
[TBL] [Abstract][Full Text] [Related]
6. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
7. Sinonasal mucosal melanoma in The Netherlands between 2001 and 2021: a clinical and epidemiological overview of 320 cases.
Scheurleer WFJ; van de Velde LJ; Devriese LA; de Ridder M; Louwman MWJ; Breimer GE; de Bree R; van Dijk BAC; Rijken JA
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38761218
[TBL] [Abstract][Full Text] [Related]
8. Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
Tong TML; Bastiaannet E; Speetjens FM; Blank CU; Luyten GPM; Jager MJ; Marinkovic M; Vu THK; Rasch CRN; Creutzberg CL; Beenakker JM; Hartgrink HH; Bosch JJJ; Kiliç E; Naus NC; Yavuzyigitoglu S; van Rij CM; Burgmans MC; Kapiteijn EHW
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001679
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
Heppt MV; Roesch A; Weide B; Gutzmer R; Meier F; Loquai C; Kähler KC; Gesierich A; Meissner M; von Bubnoff D; Göppner D; Schlaak M; Pföhler C; Utikal J; Heinzerling L; Cosgarea I; Engel J; Eckel R; Martens A; Mirlach L; Satzger I; Schubert-Fritschle G; Tietze JK; Berking C
Eur J Cancer; 2017 Aug; 81():36-44. PubMed ID: 28600969
[TBL] [Abstract][Full Text] [Related]
10. First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma.
Wang X; Haaland B; Hu-Lieskovan S; Colman H; Holmen SL
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1419. PubMed ID: 34137219
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry.
Sarac E; Amaral T; Keim U; Leiter U; Forschner A; Eigentler TK; Garbe C
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2021-2025. PubMed ID: 32078189
[TBL] [Abstract][Full Text] [Related]
12. Trends in treatment and overall survival among patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SM; van Putten M; Valkenburg-van Iersel LB; Grabsch HI; Haj Mohammad N; Hoebers FJ; Hoge CV; Jeene PM; de Jong EJ; van Laarhoven HW; Rozema T; Slingerland M; Tjan-Heijnen VC; Nieuwenhuijzen GA; Lemmens VE
World J Gastroenterol; 2019 Dec; 25(47):6835-6846. PubMed ID: 31885424
[TBL] [Abstract][Full Text] [Related]
13. Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study.
van Zeijl MCT; Haanen JBAG; Wouters MWJM; de Wreede LC; Jochems A; Aarts MJB; van den Berkmortel FWPJ; de Groot JWB; Hospers GAP; Kapiteijn EW; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van der Hoeven KJM; van den Eertwegh AJM
J Immunother; 2020 Oct; 43(8):256-264. PubMed ID: 32804914
[TBL] [Abstract][Full Text] [Related]
14. Real-world outcomes of advanced melanoma patients not represented in phase III trials.
van Zeijl MCT; Ismail RK; de Wreede LC; van den Eertwegh AJM; de Boer A; van Dartel M; Hilarius DL; Aarts MJB; van den Berkmortel FWPJ; Boers-Sonderen MJ; de Groot JB; Hospers GAP; Kapiteijn E; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; Haanen JBAG; Wouters MWJM
Int J Cancer; 2020 Dec; 147(12):3461-3470. PubMed ID: 32559817
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice.
Boer FL; Ten Eikelder MLG; van Geloven N; Kapiteijn EH; Gaarenstroom KN; Hughes G; Nooij LS; Jozwiak M; Tjiong MY; de Hullu JMA; Galaal K; van Poelgeest MIE
Gynecol Oncol; 2021 Apr; 161(1):202-210. PubMed ID: 33514483
[TBL] [Abstract][Full Text] [Related]
16. Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.
Kruijff S; Bastiaannet E; Francken AB; Schaapveld M; van der Aa M; Hoekstra HJ
Br J Cancer; 2012 Jul; 107(3):570-4. PubMed ID: 22713665
[TBL] [Abstract][Full Text] [Related]
17. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
Schaefer T; Satzger I; Gutzmer R
Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival in mucosal melanoma of the head and neck.
Jethanamest D; Vila PM; Sikora AG; Morris LG
Ann Surg Oncol; 2011 Oct; 18(10):2748-56. PubMed ID: 21476106
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.
Hao M; Zhao G; Du X; Yang Y; Yang J
Tumour Biol; 2016 Aug; 37(8):10339-48. PubMed ID: 26846098
[TBL] [Abstract][Full Text] [Related]
20. Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
van Not OJ; van den Eertwegh AJM; Haanen JB; Blank CU; Aarts MJB; van Breeschoten J; van den Berkmortel FWPJ; de Groot JB; Hospers GAP; Ismail RK; Kapiteijn E; Bloem M; De Meza MM; Piersma D; van Rijn RS; Stevense-den Boer MAM; van der Veldt AAM; Vreugdenhil G; Boers-Sonderen MJ; Blokx WAM; Wouters MWJM; Suijkerbuijk KPM
EClinicalMedicine; 2024 Mar; 69():102485. PubMed ID: 38370537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
